Boston Scientific Corp (BSX) saw an uptrend of 15408310% in the recent trading with $8230000.0 being its most recent. The current price level -0.60% lower than the highest price of $107.17 marked by the stock while trading over the past 52-weeks, whereas it is 48.21% higher than the lowest price of $71.88 the company dropped to over past 52-weeks. The latest news story on BSX appeared in (Morningstar Research) under the title “Analyst Report: Boston Scientific Corporation” on Jun-27-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 15 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.34 for the stock.
Boston Scientific Corp Earnings – What Happened With BSX
Coming around sales and income figures on BSX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Boston Scientific Corp – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.48 billion. BSX does have institutional investors; and they hold 92.17% of the stock.
As on 2024-06-30, FMR LLC was the top most holder in Boston Scientific Corp (NYSE:BSX) with an ownership of 141.46 million shares of the company or 9.6192 of the stake worth $10.89 billion. The filing also reveals VANGUARD GROUP INC as the second largest holder in the company with a control over 8.8311 of the outstanding shares. Its stake is worth $10.0 billion for having 129.87 million shares in hand.
BLACKROCK INC. also came holding a key position in the company during the recent quarter and it now holds 8.5964 of the outstanding shares. With this there are now 2300.0 institutions which have possession in BSX’s shares.
Key Metrics forBSX
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Boston Scientific Corp has a debt to equity ratio of 0.53.
Technical Analysis of Boston Scientific Corp (NYSE:BSX) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Boston Scientific Corp (BSX), we notice that the stock’s 20-day average volume is at 8,230,359 shares and 50% of short term indicators are suggesting the stock as Buy. Medium term indicators at an average of 100% are spotting the stock at Buy with its 50-day average volume of 7,521,330 shares. And to end, BSX’s 100-day average volume is 8,132,201 shares with 100% of the long-term indicators pointing towards Buy for the stock.
